<DOC>
	<DOCNO>NCT00640315</DOCNO>
	<brief_summary>This study demonstrate safety , tolerability , pharmakokinetic pharmacodynamic effect single oral dose BAY63-2521 patient pulmonary hypertension due chronic obstructive pulmonary disease ( COPD ) .</brief_summary>
	<brief_title>Single Dose Study Patients With Chronic Obstructive Pulmonary Disease ( COPD ) Associated Pulmonary Hypertension .</brief_title>
	<detailed_description>In addition pharmacodynamic pharmacokinetic variable , follow laboratory variable assess : - Hematology : Leucocytes , erythrocyte , hemoglobin , hematocrit , mean corpuscular volume ( MCV ) , mean corpuscular hemoglobin ( MCH ) , mean corpuscular hemoglobin concentration ( MCHC ) , platelet , white blood cell ( WBC ) , partial thromboplastin time ( PTT ) , prothrombin time ( Quick ) , international normalize ratio ( INR ) ( prothrombin time express relation normal value ) ; - Clinical chemistry : aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) , alkaline phosphatase ( AP ) , gamma glutamyl transpeptidase ( GGT ) , creatine phosphokinase ( CK ) , lipase , cholinesterase ( CHE ) , glucose , creatinine , urea , uric acid , bilirubin , total protein , serum albumin , sodium , potassium , calcium , chloride . And due small number subject analyze several local lab , summary statistic provide .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>Patients pulmonary hypertension due COPD , undergo routine invasive measurement hemodynamic parameter . Catheters measurement hemodynamic parameter ( PAP [ pulmonary artery pressure ] , PCWP [ pulmonary capillary wedge pressure ] , CO [ cardiac output ] , SBP [ systolic blood pressure ] ) must place independent trial . Acute exacerbation COPD , Preexisting lung disease COPD , Acute severe chronic leave heart failure , Severe coronary artery disease , Uncontrolled arterial hypertension ; Severe leave ventricular hypertrophy , Congenital acquire valvular myocardial disease , Systolic blood pressure &lt; 100 mmHg , Heart rate &lt; 55 bpm &gt; 105 bpm , PaO2 ( arterial partial oxygen pressure ) /FiO2 ( fraction inspire oxygen ) &lt; 50 mmHg , PaCO2 ( arterial partial pressure carbon dioxide ) &gt; 55 mmHg , Severe hepatic insufficiency , Severe renal insufficiency .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Chronic obstructive pulmonary disease</keyword>
	<keyword>COPD</keyword>
	<keyword>Pulmonary hypertension</keyword>
</DOC>